Variant report
Variant | nsv558792 |
---|---|
Chromosome Location | chr12:48703203-48710624 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:48702764..48705017-chr12:48706552..48708449,2 | K562 | blood: | |
2 | chr12:48699980..48703428-chr12:48704506..48706488,3 | K562 | blood: | |
3 | chr12:48699980..48703428-chr12:48704506..48706488,3 | K562 | blood: | |
4 | chr12:48699980..48702958-chr12:48704506..48706166,2 | K562 | blood: | |
5 | chr12:48702764..48705017-chr12:48706552..48708449,2 | K562 | blood: | |
6 | chr12:48698712..48702509-chr12:48702715..48705745,3 | MCF-7 | breast: | |
7 | chr12:48704261..48706305-chr12:48731702..48733217,2 | K562 | blood: | |
8 | chr12:48688262..48692290-chr12:48702214..48707293,5 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs716176 | chr12:48703203-48703204 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs555860271 | chr12:48703204-48703205 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs114582470 | chr12:48703214-48703215 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs17825134 | chr12:48703225-48703226 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs185518721 | chr12:48703230-48703231 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs190229834 | chr12:48703301-48703302 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs73291318 | chr12:48703321-48703322 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs183175065 | chr12:48703361-48703362 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187461946 | chr12:48703377-48703378 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs531369749 | chr12:48703441-48703442 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs146723154 | chr12:48703484-48703485 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1387259 | chr12:48703522-48703523 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs370293688 | chr12:48703576-48703577 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116177654 | chr12:48703689-48703690 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs116865279 | chr12:48703725-48703726 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs573364004 | chr12:48703727-48703728 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570711581 | chr12:48703760-48703761 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs148173658 | chr12:48703801-48703802 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs550098530 | chr12:48703844-48703845 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192420540 | chr12:48703905-48703906 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs75887155 | chr12:48703998-48703999 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs555468061 | chr12:48704016-48704017 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs566025453 | chr12:48704069-48704070 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs146350968 | chr12:48704083-48704084 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534811213 | chr12:48704088-48704089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558254207 | chr12:48704124-48704125 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577125478 | chr12:48704204-48704205 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs546005262 | chr12:48704219-48704220 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs150256377 | chr12:48704220-48704221 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs541033867 | chr12:48704280-48704281 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs112296288 | chr12:48704307-48704308 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs576252367 | chr12:48704318-48704319 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs183744318 | chr12:48704319-48704320 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs552932725 | chr12:48704379-48704380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs187931543 | chr12:48704388-48704389 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs571958324 | chr12:48704441-48704442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73291321 | chr12:48704444-48704445 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs192172338 | chr12:48704448-48704449 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs533379630 | chr12:48704451-48704452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs17122906 | chr12:48704474-48704475 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs529132443 | chr12:48704475-48704476 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs371616409 | chr12:48704476-48704477 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563679045 | chr12:48704481-48704482 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs184005954 | chr12:48704596-48704597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs544458174 | chr12:48704612-48704613 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs527689360 | chr12:48704640-48704641 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs187191739 | chr12:48704642-48704643 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs112297143 | chr12:48704679-48704680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs2634695 | chr12:48704697-48704698 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs139206025 | chr12:48704743-48704744 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Seminomas | 18059402 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 18632612 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Melanoma | 18172304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 17661082 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21785460 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:48699800-48705000 | Weak transcription | Fetal Heart | heart |
2 | chr12:48701200-48704000 | Weak transcription | K562 | blood |
3 | chr12:48702800-48703800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr12:48703200-48703400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
5 | chr12:48703200-48704000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
6 | chr12:48704000-48706200 | Enhancers | K562 | blood |
7 | chr12:48705000-48705400 | Enhancers | Fetal Heart | heart |
8 | chr12:48705200-48705400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr12:48705200-48705600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
10 | chr12:48705200-48706000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
11 | chr12:48705400-48707800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr12:48707800-48708000 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr12:48707800-48708000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr12:48708000-48709600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
15 | chr12:48709600-48710000 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
16 | chr12:48709600-48710200 | Weak transcription | Stomach Smooth Muscle | stomach |